Αποτελέσματα Αναζήτησης
12 Ιουλ 2020 · Dermatomyositis is an autoimmune disease that occurs in association with underlying malignancy in a subset of patients. Given this association, diagnosis of dermatomyositis typically triggers malignancy screening.
- Table - PMC - National Center for Biotechnology Information
Dermatomyositis is an autoimmune disease that occurs in...
- Dermatomyositis and malignancy - PMC - National Center for ...
There is a well-established association between...
- A Study on Dermatomyositis and the Relation to Malignancy
Multiple disease features have been linked to the...
- Cancer risk in dermatomyositis: a systematic review of the literature
The association between idiopathic inflammatory myopathy...
- Table - PMC - National Center for Biotechnology Information
There is a well-established association between dermatomyositis and malignancy. 2 A multidisciplinary approach to diagnosis and treatment involving family physicians, rheumatologists, dermatologists, and medical oncologists is important in the management of cancer-associated dermatomyositis.
30 Σεπ 2021 · Multiple disease features have been linked to the development of cancer in DM. These include: older age, male sex, skin necrosis, Gottron sign, heliotrope rash, dysphagia, low complement C4, lymphocytosis, poor response to corticosteroids and rapid disease progression.
The association between idiopathic inflammatory myopathy (IIM) and cancer has been extensively studied in adults. Many epidemiological studies demonstrated this association, which appears stronger for dermatomyositis (DM) than for polymyositis (PM).
20 Μαΐ 2024 · The evidence for an association between cancer and inflammatory myopathy includes: Epidemiologic evidence from large population studies. Temporal relationship between the diagnosis of cancer and myopathy. The improvement or resolution of myopathy after treatment of the cancer.
Cancer is a leading cause of death among adult patients with dermatomyositis (DM). Adults with DM appear to be at an increased risk of cancer, with up to 10% to 25% of patients being diagnosed with cancer within 3 years of DM diagnosis. 1 However, how best to screen for underlying cancer is debated, limited by the small scale of DM-specific ...
Cancer-associated myositis occurs most frequently for patients with dermatomyositis. (It has been estimated that as much as 20-30% of DM patients will develop cancer.) Those with polymyositis develop cancer about half as frequently as those with dermatomyositis.
